相关实验视频
Updated: Sep 16, 2025

08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
6.8K
在20,000个成人和儿科瘤中对突变过程的全面分析
Matteo Villa1, Federica Malighetti1, Luca De Sano2
1Department of Medicine and Surgery, University of Milano-Bicocca, Monza 20900, Italy.
Nucleic acids research
|July 10, 2025
概括
一个新的框架RESOLVE简化了癌症突变特征分析. 它准确地识别了关键的突变性过程,有助于癌症亚型的表征和个性化的治疗策略.
科学领域:
- 基因组学就是基因组学.
- 计算生物学 计算生物学
- 癌症研究 癌症研究
背景情况:
- 突变特征分析在癌症基因组学中至关重要,但在确定特征数量,确定病因起源和特征赋值方面面临挑战.
- 现有的方法通常依赖于启发式分析,并受到预定义的签名目录的限制.
研究的目的:
- 引入RESOLVE,一个可靠的框架,用于高效地提取,分配和对突变特征的信心估计.
- 克服当前突变特征分析的局限性,并通过活跃的突变基因过程对癌症基因组进行分层.
主要方法:
- 开发了RESOLVE (通过规范化对突变特征的可靠估计) 框架.
- 应用RESOLVE对2万个成人和儿童癌症样本.
- 利用聚类分析来识别患者组和与签名和驱动基因的关联.
主要成果:
- 比现有方法更少的签名的突变准确地适合RESOLVE,这表明主要的癌症突变过程.
- 根据特定的突变特征确定了不同的患者群体,具有预后影响.
- 在突变特征,驱动基因改变和癌症机制之间发现了强烈的关联.
结论:
- RESOLVE提供了一种有效的方法来分析突变签名,提高准确性和降低复杂性.
- 该框架为跨癌症类型的共享突变过程提供了洞察力,并有助于表征癌症亚型.
- 这些发现支持RESOLVE在通过阐明潜在的突变性机制来推进个性化癌症治疗方面的潜力.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
13.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.0K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.1K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Survival Analysis
457
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
457
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

